These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 8316137)
1. High-dose intravenous infusions of Solu-Medrol for use in acute spinal cord injuries. Woodhouse D Med J Aust; 1993 Jul; 159(1):70-1. PubMed ID: 8316137 [No Abstract] [Full Text] [Related]
9. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis. Hall ED; Wolf DL; Braughler JM J Neurosurg; 1984 Jul; 61(1):124-30. PubMed ID: 6374068 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic time window for methylprednisolone in spinal cord injured rat. Yoon DH; Kim YS; Young W Yonsei Med J; 1999 Aug; 40(4):313-20. PubMed ID: 10487132 [TBL] [Abstract][Full Text] [Related]
12. [Side effects during treatment with Solu-Medrol for optic neuritis in the course of MS]. Mazur-Chłodek L; Kaliciak-Kempińska A Klin Oczna; 2003; 105(3-4):194-6. PubMed ID: 14552184 [TBL] [Abstract][Full Text] [Related]
13. Successful renal transplantation in a patient with anaphylactic reaction to Solu-Medrol (methylprednisolone sodium succinate). Rao KV; Andersen RC; O'Brien TJ Am J Med; 1982 Jan; 72(1):161-3. PubMed ID: 7036722 [TBL] [Abstract][Full Text] [Related]
14. [Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis]. Ochudło S Wiad Lek; 1989 Dec; 41(23):1579-83. PubMed ID: 2669352 [No Abstract] [Full Text] [Related]
15. Methylprednisolone use in acute spinal cord injury. Acland RH; Anthony A; Inglis GS; Walton DI; Xiong X N Z Med J; 2001 Mar; 114(1127):99. PubMed ID: 11297147 [No Abstract] [Full Text] [Related]
16. Can high-dose methylprednisolone be diluted? Lee NP Crit Care Nurse; 1994 Dec; 14(6):18-9. PubMed ID: 7712796 [No Abstract] [Full Text] [Related]
17. Localized delivery of methylprednisolone sodium succinate with polymeric nanoparticles in experimental injured spinal cord model. Karabey-Akyurek Y; Gurcay AG; Gurcan O; Turkoglu OF; Yabanoglu-Ciftci S; Eroglu H; Sargon MF; Bilensoy E; Oner L Pharm Dev Technol; 2017 Dec; 22(8):972-981. PubMed ID: 26895158 [TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury. Barth J; Winkler J; Schumann R; Nagaraja NV; Madabushi R; Balbach S; Derendorf H; Möllmann H; Möllenhoff G Int J Clin Pharmacol Ther; 2004 Sep; 42(9):504-11. PubMed ID: 15487809 [TBL] [Abstract][Full Text] [Related]
19. A double-blind randomized crossover study to compare the antiemetic efficacy of 250 mg with 500 mg methylprednisolone succinate (Solu-Medrol) as a single intravenous dose in patients treated with noncisplatin chemotherapy. Pieters RC; Vermorken JB; Gall HE; Nauta JJ; van Loenen AC; van Groeningen CJ; van Rijswijk RE; Brenninkmeijer JH; Pinedo HM Oncology; 1993; 50(4):316-22. PubMed ID: 8497383 [TBL] [Abstract][Full Text] [Related]
20. Methylprednisolone and spinal cord injury. Young W J Neurosurg; 2002 Jan; 96(1 Suppl):141-2. PubMed ID: 11795708 [No Abstract] [Full Text] [Related] [Next] [New Search]